Document Detail


Cytomegaloviremia after autografting for leukemia: clinical significance and lack of effect on engraftment.
MedLine Citation:
PMID:  9177437     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
One hundred and fourteen patients with leukemia (66 cytomegalovirus (CMV)-seropositive and 48 CMV-seronegative) were monitored for cytomegaloviremia by early antigen detection or conventional viral culture after autologous stem cell transplantation (ASCT). Twenty-two episodes of viremia were seen at 2-36 weeks (median 11) in 14 seropositive patients. Nineteen resolved without therapy in 11 patients. Three patients with clinical features suggestive of CMV disease were treated with ganciclovir: viremia resolved prior to ganciclovir in one, and with 3 weeks of ganciclovir in the other two. Transient thrombocytopenia (n = 4) and leukopenia (n = 1) were seen in association with five episodes of viremia. The counts recovered in all five patients; with ganciclovir (n = 2) or with spontaneous clearance of viremia (n = 3). One seronegative patient developed viremia which resolved spontaneously in 3 weeks. No symptoms suggestive of CMV disease were seen in any of the other patients. CMV serostatus or development of CMV infection did not affect hematologic recovery. In our experience, cytomegaloviremia is relatively uncommon after autografting for leukemia, and usually does not require treatment. We now do not routinely monitor leukemia patients for CMV infection after autografting, but look for viremia in CMV-seropositive patients with unexplained fever, drop in blood counts, lung infiltrates, or gastrointestinal symptoms.
Authors:
S Singhal; R Powles; J Treleaven; C Horton; C R Pinkerton; S Meller; J Mehta
Related Documents :
18833397 - Characterization of virologic failure after an initially successful 48-week course of a...
19965947 - Prophylactic antivirals may be helpful in prevention of varicella-zoster virus reactiva...
21722557 - Steroids for patients in septic shock: the results of the corticus trial.
8780817 - Development of resistance of zidovudine (zdv) and didanosine (ddi) in hiv from patients...
21145427 - Renal dysfunction is the most important independent predictor of mortality in cirrhotic...
8418457 - Noncontraceptive benefits of oral contraceptive agents. patients should know the positi...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Leukemia     Volume:  11     ISSN:  0887-6924     ISO Abbreviation:  Leukemia     Publication Date:  1997 Jun 
Date Detail:
Created Date:  1997-07-02     Completed Date:  1997-07-02     Revised Date:  2013-03-04    
Medline Journal Info:
Nlm Unique ID:  8704895     Medline TA:  Leukemia     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  835-8     Citation Subset:  IM    
Affiliation:
Leukaemia Unit, Royal Marsden Hospital, Surrey, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Antiviral Agents / therapeutic use
Child
Child, Preschool
Cytomegalovirus Infections / drug therapy,  epidemiology*
Ganciclovir / therapeutic use
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia / therapy*
Leukocyte Count
Middle Aged
Morbidity
Neutrophils / physiology
Platelet Count
Probability
Prospective Studies
Retrospective Studies
Time Factors
Transplantation, Autologous
Viremia / drug therapy,  epidemiology*
Chemical
Reg. No./Substance:
0/Antiviral Agents; 82410-32-0/Ganciclovir

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CD34+ megakaryoblastic leukaemic cells are CD38-, but CD61+ and glycophorin A+: improved criteria fo...
Next Document:  Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.